It is important that clinicians and laboratorians, including clinical chemists and pathologists, recognize and understand the clinical significance of abnormal liver function tests. The liver regulates many important metabolic functions. Hepatic injury is associated with distortion of these metabolic functions. Hepatic disease can be evaluated and diagnosed by determining serum concentrations of a number of serum analytes. Many serum analytes exist to assist in the biochemical diagnosis of liver disease. The focus of this paper is on the analytes which are associated with hepatic necrosis, cholestasis, defects in excretion and end stage hepatic disease which results in decreased synthetic function. The abnormalities of these serum analytes will be correlated with the important types of liver disease.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Tygstrup, N. (1990) Assessment of liver function: Principles and practice. J. Gastroenterol. Hepatol. 5, 468–682.
Corless, J.K. and Middleton, H.M. III. (1983) Normal liver function: A basis for understanding hepatic disease. Arch. Intern. Med. 143, 2291–2294.
Skrede, S., Solberg, H.E., Ritland, S., Blomhoff, J.P., Schrumpf, E., Elgjo, K. and Gjone, E. (1982) Diagnostic and prognostic value of laboratory tests assessed in a follow-up study of 200 patients with liver disease. Clin. Chem. 28, 1177–1181.
Reichling, J.J. and Kaplan, M.M. (1988) Clinical use of serum enzymes in liver disease. Dig. Dis. Sci. 33, 1601–1614.
Killingsworth, L.M. (1979) Plasma protein patterns in health and disease. Crit. Rev. Clin. Lab. Sci. 11, 1–30.
Peters, T. Jr. (1975) Serum albumin. In: The-plasma proteins Ed. F. Putman, Academic Press, New York, USA, 2nd. edn. Vol1. p. 133.
Pinnel, A.E. and Northam, B.E. (1978) New automated dye-binding method for serum albumin determination with bromcresol purple. Clin. Chem. 24, 80–86.
Blanchaert, M. (1980) Analysis of bilirubin and bilirubin mono-and di-conjugates. Biochem. J. 185, 115–128.
Doumas, B.T., Perry, B.W., Sasse, E.A and Straumfjord, J.V. Jr. (1973) Standardization in bilirubin assays: Evaluation of selected methods and stability of bilirubin solutions. Clin. Chem. 19, 984–993.
Lott, J.A. and Wolf, P.L. Alanine and aspartate aminotransferase (ALT and AST). In: Clin. Enzymol. Eds. Lott, J.A., Wolf, P.L., Yearbook Medical Publishers, Chicago, USA. 111–157.
Pantenghini, M., Malechiodi, A., Calarco M. and Bonora, R. (1984) Clinical and diagnostic significance of aspartate aminotransferase isoenzymes in sera of patients with liver diseases. J. Clin. Chem. Clin. Biochem. 22, 153–158.
DeRitis, F. and Cacciatora, L. (1983) Differential diagnosis of liver diseases. In: Clin. Hepatol. Eds. Csomos, G., Thaler, H., Springer-Verlag, Berlin, Germany. 16–28.
Nalpas, B., Vassault, A. and LeGuilon, A. (1984) Serum activity of mitochondrial aspartate aminotransferase; a sensitive marker of alocoholism with or without alcoholic hepatitis. Hepatology. 4, 893–896.
Schmidt, E. and Schmidt, F.W. (1990) Progress in the enzyme diagnosis of liver disease; reality or illusion? Clin. Biochem. 23, 375–382.
Lott, J.A. and Landesman, P.W. (1984) The enzymology of skeletal muscle disorders. Crit. Rev. Clin. Lab. Sci. 20, 153–190.
Rosalki, S.B. (1989) Serum enzymes in disease of skeletal muscle. Clin. Lab. Med. 9, 767–781.
Wolf, P.L., Lott, J.A., Nitti, G.J. and Bookstein, R. (1987) Changes in serum enzymes, lactate and haptoglobin following acute physical stress in international class athletes. Clin. Biochem. 20, 73–77.
Wolf, P.L. (1994) Clinical significance of serum high-molecular-mass alkaline phosphatase, alkaline phosphatase-lipoprotein-x complex, and intestinal variant alkaline phosphatase. Jour. Clin. Lab. Anal. 81, 172–176.
Wolf, P.L. (1990) High-molecular-weight alkaline phosphatase and alkaline phosphatase lipoprotein x complex in cholestasis and hepatic malignancy. Arch. Pathol. Lab. Med. 114, 577–579.
Van Hoof, V. and DeBroe, M.E. (1994) Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns. Crit. Rev. Clin. Lab. Sci. 31(3), 197–293.
Wolf, P.L. (1978) Clinical significance of an increased or decreased serum alkaline phosphatase. Arch. Pathol. Lab. Med. 102, 497–501.
Birkett, D.J., Done, J., Neale, F.C. and Posen, S. (1966) Serum alkaline phosphatase in pregnancy; an immunological study. Br. Med. J. 1, 1210–1212.
Siraganian, P.A., Mulvihill, J.J., Mulivor, R.A. and Miller, R.W. (1989) Benign familial hyperphosphatasemia. J. Am. Med. Assoc. 261, 1310–1312.
Wolf, P.L. (1995) The significance of transient hyperphosphatasemia of infancy and childhood to the clinician and clinical pathologist. Arch. Pathol. Lab. Med. 119, 774–775.
Moss, D.W. (1982) Alkaline phosphatase isoenzymes. Clin. Chem. 28, 2007–2016.
Van Hoof, V.O., Lepoutre, L.G., Hoylaerts, M.F., Chevigne, R. and DeBroe, M.E. (1988) Improved agarose electrophoretic method for separating alkaline phosphatase isoenzymes in serum. Clin. Chem. 34, 1857–1862.
Rosalki, S.B., Foo, A.Y., Burlina, A., Prellwitz, W., Stieber, P., Neumeier, D., Klein, G., Poppe, W.A. and Bodenmuller, H. (1993) Multicentric evaluation of Iso-ALP test kit for measurement of bone alkaline phosphatase in serum and plasma. Clin. Chem. 39, 648–652.
Hill, C.S. and Wolfert, R.L. (1989) The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase. Clin. Chim. Acta. 186, 315–320.
Bradbeer, J.N., Zanelli, J.M., Lindsay, P.C., Pearson, J. and Reeve, J. (1992) Relationship between the location of osteoblastic alkaline phosphatase activity and bone formation in human iliac crest bone. J. Bone Min. Res. 7, 905–912.
Moss, D.W. (1992) Changes in enzyme expression related to differentiation and regulatory factors: the acid phosphatase of osteoclasts and other macrophages. Clin. Chim. Acta. 209, 131–138.
Van Hoof, V.O., Van Oosterom, A.T., Lepoutre, L.G. and DeBroe, M.E. (1992) Alkaline phosphatase isoenzyme patterns in malignant disease. Clin. Chem. 38, 2546–2551.
Fishman, W.H., Inglis, N.R., Stolbach, L.L. and Krant, M.J. (1968) A serum alkaline phosphatase isoenzymes of human neoplastic cell origin. Cancer Res. 28, 150–154.
Nathanson, L. and Fishman, W. (1971) New observations on the Regan isoenzyme of alkaline phosphatase in cancer patients. Cancer 27, 1388–1397.
Stolbach, L., Krant, M. and Fishman, W. (1969) Ectopic production of alkaline phosphatase isoenzyme in patients with cancer. New Engl. J. Med. 281, 757–762.
Hada, T., Higashino, K., Okochi, T. and Yamamura, Y. (1978) Kasahara-variant alkaline phosphatase in renal cell carcinoma. Clin. Chim. Acta. 89, 311–316.
Tietz, N.W., Burtis, C.A., Duncan, P., Erwin, K., Petitclerc, C.J., Rinker, A.D., Shuey, D. and Zygowic, E.R. (1983) A reference m of gamma-glutamyl transferase. CRC Crit. Rev. Clin. Lab. Sci. 12, 1–58.
Burlina, A. (1978) Improved method of fractionating gamma-glutamyl transferase by electrophoresis on cellulose acetate. Clin. Chem. 24, 502–504.
Rosalki, S.B. and Rau, D. (1972) Serum gamma-glutamyl transpeptidase activity in alcoholism. Clin. Chim. Acta. 39, 41–47.
Nemesanszky, E., Lott, J.A. and Arato, M. (1988) Changes in serum enzymes in moderate drinkers after an alcohol challenge. Clin. Chem. 34, 525–527.
Sacchetti, L., Castaldo, G. and Salvatore, F. (1988) The γ-glutamyltransferase isoenzyme pattern in serum as a signal discriminating between hepatobiliary diseases, including neoplasias. Clin. Chem. 34, 352–355.
Eriksen, J., Olsen, P.S. and Thomsen, A.C. (1984) Gamma-glutamyl-transpeptidase, aspartate aminotransferase, and erythrocyte mean corpuscular volume as indicators of alcohol consumption in liver disease. Scand. J. Gastroenterol. 19, 813–819.
Acheampong-Mensah, D. (1976) Activity of gamma-glutamyl-transpeptidase in serum of patients receiving anticonvulsant or anticoagulant therapy. Clim. Biochem. 9, 67–70.
Rosalki, S.B., Tarlow, D. and Rau, D. (1971) Plasma gamma-glutamyl-transpeptidase elevation in patients receiving enzyme-inducing drugs. Lancet ii 376–377.
Cullen, D.R. and Goldberg, D.M. (1976) The association between serum triglycerides and GGT activity in diabetes mellitus. Clin. Biochem. 9, 208–211.
Humphries, B.A., Melnychuk, M., Donegan, E.J. and Snee, R.D. (1979) Automated enzymatic assay for plasma ammonia. Clin. Chem. 25, 26–30.
Mitchell, R.A., Partin, J.C., Partin, J.S. and Ram, M.L. (1985) Hepatic and encephalopathic components of Reye's syndrome: Factor analysis of admission data from 209 patients. Neurology. 35, 1236–1239.
Mondzac, A., Ehrlich, G.E. and Seegmiller, J.E., (1965) An enzymatic determination of ammonia in biological fluids. J. Lab. Clin. Med. 66, 526–531.
Shahangian, S., Ash, K.O., Wahlstrom, N.O. Jr., Warden, J.D., Saffle, J.R., Taylor, A. Jr. and Green, L.S. (1984) Creatine kinase and lactate dehydrogenase isoenzymes in serum of patients suffering burns, blunt trauma, or myocardial infarction. Clin. Chem. 30, 1332–1338.
Bruns, D.E., Savory, J. and Wills, M.R. (1984) More on “flipped” lactate dehydrogenase patterns in myocardial infarction. Clin. Chem. 30, 1881–1882.
Ketchum, C.H., Robinson, C.A., Hall, L.M. and Grizzle, W.E. (1984) Clinical significance and partial biochemical characterization of lactate dehydrogenase isoenzyme 6. Clin. Chem. 30, 46–49.
Wolf, P.L. (1985) Lactate dehydrogenase-6: A biochemical sign of serious hepatic circulatory disturbance. Arch. Intern. Med. 145: 1396–1397.
Kato, S., Ishii, H., Kano, S., Horii, K. and Tsuchiya, M. (1984) Evidence that “lactate dehydrogenase isoenzyme 6” is in fact alcohol dehydrogenase. Clin. Chem. 30, 1585–1586.
Gambino, R. (1980) Wilson's disease, an early diagnosis is essential. Lab. Rep. Physic. 51–54.
Wolf, P.L., Ray, G. and Kaplan, H. (1979) Evaluation of copper oxidase (ceruloplasmin) and related tests in Hodgkin's disease. Clin. Biochem. 12, 202–204.
Wolf, P.L. (1982) Ceruloplasmin: Methods and clinical use. CRC Crit. Rev. Lab. Sci. 17, 229–245
Wolf, P.L., Enlander, D., Dalziel, J. and Swanson, J. (1969) Green plasma in blood donors. New Eng. Jour. Med. 281, 205–206.
Wald, N.J. and Cuckle, H.S. (1982) Nomogram for estimating an individual's risk of having a fetus with open spina bifida. Br. J. Obstet. Gynaecol. 89, 598–604.
Wolf, P.L. (1996) In: Enzyme tests in body fluids other than blood and urine. Chapter 20 Amniotic Fluid in Enzyme Tests in Diagnosis. Moss, D.W. and Rosalki, S.B. Eds. Edwards Arnold Publisher, London, U.K. p 270–271.
Balistreri, W.F., Suchy, F.J., Farrell, M.K. and Heubi, J.E. (1981) Pathologic versus physiologic cholestasis: Elevated serum concentration of a secondary bile acid in the presence of hepatobiliary disease. J. Pediatr. 98, 399–402.
Danielsson, H. and Sjovall, J. (1975) Bile acid metabolism. Ann. Rev. Biochem. 44, 233–253.
Bean, P., Liegmann, K., Lovli, T., Westby, C. and Sundrehagen, E. (1997) Semiautomated procedures for evaluation of carbohydrate-deficient transferrin in the diagnosis of alcohol abuse. Clin. Chem. 43, 6983–6989.
Stibler, H. (1991) Carbohydrate-deficient transferrin in serum; a new marker of potentially harmful alcohol consumption reviewed. Clin. Chem. 37, 2029–2037.
Anton, R. and Bean, P. (1994) Two methods for measuring carbohydrate-deficient transferrin in inpatient alcoholics and healthy controls compared. Clin. Chem. 40, 364–368.
Doyle, K.M., Cluette-Brown, J.E., Dube, O.M., Bernhardt, T.G., Morse, C.R. and Laposata, M. (1996) J. Am. Med. Assoc. 176, 1152–1156.
Doyle, K.M., Bird, D.A., al-Salihi, S., Hallag, Y., Cluete-Brown, J.E., Goss, K.A. and Laposata, M. (1994) Fatty acid ethyl esters are present in human serum after ethanol ingestion. J Lipid Res. 35, 428–437.
Betro, M.G. (1972) Significance of increased alkaline phosphatase and lactate dehydrogenase activities coincident with normal serum bilirubin. Clin. Chem. 18, 1429.